Hepatitis C

Top Story

Patients with HCV engage in risky behavior, causing excess mortality

August 14, 2017

Health risk behaviors, such as alcohol use, cigarette smoking and unhealthy diets, contributed equally toward mortality risk for patients with chronic hepatitis C as the infection itself, according to a recently published study.

“Individuals with [chronic HCV] infection in the U.S. exhibit a considerable excess mortality risk. Yet, about half of this excess may reflect high levels of [health risk behaviors] as opposed to the effects of [chronic HCV] infection itself,” Hamish Innes, MD, from Glasgow Caledonian University, and colleagues wrote. “This study therefore highlights the importance of a public health response to hepatitis C that includes action on [health risk behaviors] as well as access to antiviral therapy.”

Guest Commentary: Prevention, education essential to eliminating viral hepatitis

August 11, 2017
In this guest commentary, Thelma King Thiel, RN, BA, former CEO of both the American Liver Foundation and the Hepatitis Foundation International
Meeting News

Indigenous people bear ‘disproportionately high burden’ of hepatitis

August 8, 2017
Citizens of indigenous nations are up to 10 times more likely to have hepatitis B or hepatitis C than the general population in their respective countries, according to…
Meeting News

Universal screening in Cherokee Nation aims to eliminate hepatitis C

August 8, 2017
Nearly half of the Cherokee Nation American Indian population received screening for hepatitis C and approximately one-quarter of those with the infection are cured…
More Headlines »

Rapid Response from Barcelona: New Data in HCV Treatment

This activity is supported by an educational grant from AbbVie and Merck & Co., Inc.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

Meeting News Coverage

VIDEO: Sofosbuvir/velpatasvir may offer improved patient reported outcomes

June 6, 2016
More »